Dual role of oestrogens as hormones and pro-carcinogens: Tumour initiation by metabolic activation of oestrogens

European Journal of Cancer Prevention

Volumn 6, Issue 1, 1997, Pages 3-10

  Liehr, J G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Free radical generation; mammary glands; metabolic redox cycling; oestrogens

Indexed keywords

CARCINOGEN; CATECHOL ESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; FREE RADICAL;

BREAST CANCER; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; DNA DAMAGE; GROWTH STIMULATION; MALIGNANT TRANSFORMATION; METABOLIC ACTIVATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOTRANSFORMATION; BREAST NEOPLASMS; CARCINOGENS; DNA DAMAGE; ESTROGENS, CONJUGATED (USP); FEMALE; FREE RADICALS; HUMANS; MAMMARY NEOPLASMS, ANIMAL; RISK ASSESSMENT;

EID: 0030960296     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199702000-00002     Document Type: Review

References (75)

1. Abul-Hajj YJ, Tabakovic K, Tabakovic I (1995). An estrogen- nucleic acid adduct. Electroreductive intermolecular coupling of 3,4-estrone-o-quinone and adenine. J Am Chem Soc 117: 6144-5.
2. Aldercreutz H, Gorbach SL, Goldin BR et al (1994). Estrogen metabolism and excretion in oriental and caucasian women. J Natl Cancer Inst 86: 1076-82.
3. Aoyama T, Korzekwa K, Nagata K et al (1990). Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome. Endocrinology 126: 3101-6.
4. Banerjee SK, Banerjee S, Li SA, Li JJ (1994). Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mutation Res 311: 191-7.
5. Barnea ER, MacLusky NJ, Naftolin F (1983). Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids 41: 643-56.
6. Boyd NF, McGuire V (1991). The possible role of lipid peroxidation in breast cancer risk. Free Radical Biol Med 10: 185-90.
7. Bui QD, Weisz J (1989). Monooxygenase mediating catecholestrogen formation by rat anterior pituitary is an estrogen-4-hydroxylase. Endocrinology 124: 1085-7.
8. Castagnetta LA, Granata OM, Arcuri FP et al (1992). Gas chromatography/mass spectrometry of catecholestrogens. Steroids 57: 437-43.
9. Clifton KH, Meyer RK (1956). Mechanism of anterior pituitary tumor induction by oestrogen. Anat Rec 125: 65-81.
10. Colditz GA, Hankinson SE, Hunter DJ et al (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589-93.
11. Greenberg ER, Barnes AB, Resseguie L et al (1984). Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 311: 1393-8.
12. Greenwald P, Caputo TA, Wolfgang PE (1977). Endometrial cancer after menopausal use of estrogens. Obstet Gynecol 50: 239-43.
13. Guengerich FP (1989). Characterization of human microsomal cytochrome P450 enzymes. Ann Rev Pharmacol Toxicol 29: 241-64.
14. Hammond DK, Zhu BT, Wang MY, Ricci MJ, Liehr JG (1997). Cytochrome P450 metabolism of estrogen in hamster liver and kidney. Toxicol Appl Pharmacol (In press).
15. Han X, Liehr JG (1994a). DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens. Hormone- induced free radical damage preceding renal malignancy. Carcinogenesis 15: 977-1000.
16. Han X, Liehr JG (1994b). 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res 54: 5515-7.
17. Han X, Liehr JG (1995). Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 16: 2571-4.
18. Hayes CL, Spink DC, Spink BC et al (1996). 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93: 9776-81.
19. Henderson BE, Ross RK, Pike MC (1991). Toward the primary prevention of cancer. Science 244: 1131-8.
20. Hendersen BE, Ross RK, Pike MC (1993). Hormonal chemoprevention of cancer in women. Science 259: 633-8.
21. Howe ER, Hirohata T, Hislop TG et al (1990). Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst 82: 561-9.
22. Hulka BS, Liu ET, Lininger RA (1993). Steroid hormones and risk of breast cancer. Cancer 74: 1111-24.
23. Jellinck PH, Krey L, Davis PG et al (1981). Central and peripheral actions of estradiol and catechol estrogens administered at low concentrations at constant infusion. Endocrinology 108: 1848-54.
24. Jick H, Walker HM, Rothman KJ (1980). The epidemic of endometrial cancer: a commentary. Am J Public Health 70: 264-7.
25. Kerlan V, Dreano Y, Bercovici JP et al (1992). Nature of cytochrome P450 involved in the 2/4 hydroxylation of estradiol in human liver microsomes. Biochem Pharmacol 44: 1745-56.
26. Key TJA, Pike MC (1988). The role of estrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29-43.
27. Kirkman H (1959). Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr No. 1 1-57.
28. Li JJ, Gonsalez A, Banerjee S, Banerjee SK, Li SA (1993). Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ Health Perspect 101: 259-64.
29. Liehr JG (1983). 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 23: 278-81.
30. Liehr JG, Wheeler WJ (1983). Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C. Cancer Res 43: 4638-42.
31. Liehr JG, Sirbasku DA (1985). Estrogen-dependent kidney tumors. In Tissue Culture of Epithelial Cells (ed Taub M); Plenum Press, New York, pp. 205-34.
32. Liehr JG, Stancel GM, Chorich LP, Bousfield GR, Ulubelen AA (1986a). Hormonal carcinogenicity: separation of estrogenicity from carcinogenicity. Chem Biol Interact 59: 173-84.
33. Liehr JG, Ulubelen AA, Strobel HW (1986b). Cytochrome P-450- mediated redox cycling of estrogens. J Biol Chem 261: 16865-70.
34. Liehr JG, Fang WF, Sirbasku DA, Ulubelen AA (1986c). Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24: 353-6.
35. Liehr JG, Avitts TA, Randerath E, Randerath K (1986d). Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 83: 5301-5.
36. Liehr JG, Purdy RH, Baran JS et al (1987). Correlation of aromatic hydroxylation of 11β-substituted estrogens with neoplastic transformation in vitro but not with in vivo tumor induction by these hormones. Cancer Res 47: 2583-8.
37. Liehr JG, Roy D, Gladek A (1989). Mechanism of inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by vitamin C. Carcinogenesis 10: 1983-8.
38. Liehr JG, Gladek A, Macatee T, Randerath E, Randerath K (1991). DNA adduct formation in liver and kidney of male Syrian hamsters treated with estrogen and/or α-naphthoflavone. Carcinogenesis 12: 385-9.
39. Liehr JG, Ricci MJ, Jefcoate CR et al (1995). 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92: 9220-4.
40. Liehr JG, Ricci MJ (1996). 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc Natl Acad Sci USA 93: 3294-6.
41. Liehr JG (1997). Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect (in press).
42. Lottering ML, Haag M, Seegers JC (1992). Effects of 17β-estradiol metabolites on cell cycle events in MCF-7 cells. Cancer Res 52: 5926-32.
43. Malins DC, Holmes EH, Polissar NL, Gunselman SJ (1993). The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71: 3036-43.
44. Martucci C, Fishman J (1976). Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3, 15α, 16α, 17β-tetrol). Steroids 27: 325-34.
45. Martucci C, Fishman J (1979). Impact of continuously administered catechol estrogens on uterine growth and LH secretion. Endocrinology 105: 1288-92.
46. Martucci CP, Fishman J (1993). P450 enzymes of estrogen metabolism. Pharmacol Ther 57: 237-57.
47. Newbold RR, Bullock BC, McLachlan JA (1990). Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50: 7677-81.
48. Nutter LM, Ngo EO, Abut-Hajj YJ (1991). Characterization of DNA damage induced by 3,4-estrone-o-quinone in human cells. J Biol Chem 226: 16380-6.
49. Nutter LM, Wu YY, Ngo EO et al (1994). An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem Res Toxicol 7: 23-8.
50. Paria BC, Chakraborty C, Dey SK (1990). Catechol-estrogen formation in mouse uterus and its role in implantation. Mol Cell Endocrinol 69: 25-31.
51. Peterson OW, Hoyer PE, van Deurs B (1987) Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res 47: 5748-51.
52. Rosier JA, van Peteghem CH (1989). Peroxidative in vitro metabolism of diethylstilbestrol induces formation of 8-hydroxy-2′-deoxyguanosine. Carcinogenesis 10: 405-6.
53. Roy D, Liehr JG (1988). Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. J Biol Chem 263: 3646-51.
54. Roy D, Liehr JG (1990). Inhibition of estrogen-induced kidney carcinogenesis in Syrian hamsters by modulators of estrogen metabolism. Carcinogenesis 11: 567-70.
55. Roy D, Floyd RA, Liehr JG (1991). Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. Cancer Res 51: 3882-5.
56. Roy D, Liehr JG (1992). Target organ-specific inactivation of drug metabolizing enzymes in kidney of hamsters treated with estradiol. Mol Cell Biochem 110: 31-9.
57. Savas U, Bhattacharya KK, Christou M, Alexander DL, Jefcoate CR (1994). Mouse cytochrome P-450EF, representative of a new IB subfamily of cytochrome P-450s. Cloning, sequence determination and tissue expression. J Biol Chem 269: 14905-11.
58. Schneider J, Huh MM, Bradlow HL, Fishman J (1984). Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259: 4840-5.
59. Schütze N, Vollmer G, Knuppen R (1994). Catechol-estrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells. J Steroid Biochem Mol Biol 48: 453-61.
60. Schütze N, Vollmer G, Tiemann I, Geiger M, Knuppen R (1993). Catecholestrogens are MCF-7 cell estrogen receptor agonists. J Steroid Biochem Mol Biol 46: 781-9.
61. Shigeta H, Newbold RR, McLachlan JA, Teng C (1996). Estrogenic effect on the expression of estrogen receptor. COUP-TF, and lactoferrin mRNA in developing mouse tissue. Mol Repro Dev 45: 21-30.
62. Slaunwhite WR, Kirdani RY, Sandberg AA (1973). Metabolic aspects of estrogens in man. In Handbook of Physiology Section 7: Endocrinology, Vol. II, Part 1 (eds Greep RO, Astwood EB, Geiger SR); American Physiological Society, Washington DC, pp. 485-523.
63. Spink DC, Hayes GL, Young NR et al (1994). The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase. J Steroid Biochem Mol Biol 51: 251-8.
64. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL (1996). Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 9: 851-9.
65. Sutter TR, Tang YM, Hayes CL et al (1994). Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269: 13092-9.
66. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A et al (1995). A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 87: 190-7.
67. Tsutsui T, Suzuki N, Maizumi H, McLachlan JA, Barret JC (1986). Alteration in diethylstilbestrol-induced mutagenicity and cell transformation by exogenous metabolic activation. Carcinogenesis 7: 1415-8.
68. Tsutsui T, Suzuki N, Fukuda S et al (1987). 17β-estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in culture. Carcinogenesis 8: 1715-9.
69. Vandewalle B, Lefebvre J (1989). Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61: 239-46.
70. Wang MY, Liehr JG (1995a). Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis 16: 1941-5.
71. Wang MY, Liehr JG (1995b). Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch Biochem Biophys 316: 38-46.
72. Wang MY, Dhingra K, Hittelman WN et al (1996). Lipid peroxidation-induced (Malondialdehyde) DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev 5: 705-10.
73. Weisz J, Bui QD, Roy D, Liehr JG (1992). Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation estrogens. Endocrinology 131: 655-61.
74. 3H]-hydride reduction. J Biol Chem 266: 14446-50.
75. Yan ZJ, Roy D (1995). Mutations in DNA polymerase β mRNA of stilbene estrogen-induced kidney tumors in Syrian hamster. Biochem Mol Biol Int 37: 175-83.